UiPath (PATH – Free Report) appears an attractive pick given a noticeable improvement in the company’s earnings outlook. The stock has been a strong performer lately, and the momentum might continue with analysts still raising their earnings estimates for the company.
Analysts’ growing optimism on the earnings prospects of this enterprise automation software developer is driving estimates higher, which should get reflected in its stock price. After all, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements. Our stock rating tool — the Zacks Rank — has this insight at its core.
The five-grade Zacks Rank system, which ranges from a Zacks Rank #1 (Strong Buy) to a Zacks Rank #5 (Strong Sell), has an impressive externally-audited track record of outperformance, with Zacks #1 Ranked stocks generating an average annual return of +25% since 2008.
For UiPath, strong agreement among the covering analysts in revising earnings estimates upward has resulted in meaningful improvement in consensus estimates for the next quarter and full year.
The chart below shows the evolution of forward 12-month Zacks Consensus EPS estimate:
12 Month EPS
Current-Quarter Estimate Revisions
For the current quarter, the company is expected to earn $0.10 per share, which is a change of -23.08% from the year-ago reported number.
Over the last 30 days, the Zacks Consensus Estimate for UiPath has increased 22.22% because two estimates have moved higher while three have gone lower.
Current-Year Estimate Revisions
For the full year, the company is expected to earn $0.53 per share, representing a year-over-year change of 0%.
The revisions trend for the current year also appears quite promising for UiPath, with seven estimates moving higher over the past month compared to one negative revision. The consensus estimate has also received a boost over this time frame, increasing 58.04%.
Favorable Zacks Rank
Thanks to promising estimate revisions, UiPath currently carries a Zacks Rank #1 (Strong Buy). The Zacks Rank is a tried-and-tested rating tool that helps investors effectively harness the power of earnings estimate revisions and make the right investment decision. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Our research shows that stocks with Zacks Rank #1 (Strong Buy) and 2 (Buy) significantly outperform the S&P 500.
Bottom Line
While strong estimate revisions for UiPath have attracted decent investments and pushed the stock 6.6% higher over the past four weeks, further upside may still be left in the stock. So, you may consider adding it to your portfolio right away.
Financial Market Newsflash
No financial news published today. Check back later.